Minimal-access surgery for staging of malignant melanoma.

OBJECTIVE To develop a simple, minimally invasive technique of determining whether regional node metastasis has occurred in patients with melanoma. SETTING Teaching hospital tertiary care and private practice settings. PATIENTS Between February 1993 and October 1994, 121 patients with invasive malignant melanoma and clinically negative lymph nodes were enrolled in this clinical trial. DESIGN Consecutive sample clinical trial. Within 24 hours prior to lymph node resection, a radioactive tracer was injected into the dermis around the site of the primary melanoma. Forty-four patients also had blue dye injected immediately prior to surgical resection. Measurement of radioactivity in the lymph nodes and surgical localization were made using a handheld gamma detector. Radiolabeled nodes were selectively removed with the least dissection possible. In patients with pathologically positive radiolabeled nodes, regional lymphadenectomy was performed. OUTCOME MEASURES Successful identification of radiolabeled sentinel lymph nodes, correlation of radiolabeling with injection of blue dye, and regional node recurrence rate. RESULTS Surgeons successfully resected the radiolabeled sentinel lymph nodes in 118 (98%) of 121 patients. One hundred percent of blue-stained lymph nodes were successfully radiolabeled. Fifteen patients had pathologically positive sentinel lymph nodes. In 10 patients, the sentinel node was the only node with metastasis. Two systemic and one regional node recurrences occurred during a mean follow-up of 220 days. CONCLUSIONS Selective gamma probe-guided resection of the radiolabeled sentinel lymph node is possible in over 95% of patients with melanoma. This technique offers a simple and reliable method of staging of regional lymph nodes in these patients without performing a regional lymphadenectomy.

[1]  F. Sim,et al.  Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. , 1986, Mayo Clinic proceedings.

[2]  N. Cascinelli,et al.  Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma. , 1991, Archives of surgery.

[3]  K. Drzewiecki,et al.  Preoperative cutaneous lymphoscintigraphy in malignant melanoma , 1989, Cancer.

[4]  A. Kopf,et al.  Local and In‐Transit Metastases Following Definitive Excision for Primary Cutaneous Malignant Melanoma , 1983, Annals of surgery.

[5]  S. Singletary,et al.  Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. , 1989, Archives of surgery.

[6]  M. Ross,et al.  The Orderly Progression of Melanoma Nodal Metastases , 1994, Annals of surgery.

[7]  T. K. Gupta.  Results of treatment of 269 patients with primary cutaneous melanoma: a five-year prospective study. , 1977, Annals of surgery.

[8]  R. Clark,et al.  Lymphoscintigraphy in malignant melanoma. , 1992, Annals of plastic surgery.

[9]  C. Balch.  Surgical management of regional lymph nodes in cutaneous melanoma. , 1980, Journal of the American Academy of Dermatology.

[10]  W. N. Tauxe,et al.  Technetium-99m sulfur-colloid cutaneous lymphoscintigraphy in the management of truncal melanoma. , 1979, Radiology.

[11]  C. Balch,et al.  A Comparison of Prognostic Factors and Surgical Results in 1,786 Patients with Localized (Stage I) Melanoma Treated in Alabama, USA, and New South Wales, Australia , 1982, Annals of surgery.

[12]  D. Weaver,et al.  Gamma-probe-guided lymph node localization in malignant melanoma. , 1993, Surgical oncology.

[13]  W. Clark,et al.  A rational approach to the surgical management of melanoma. , 1977 .

[14]  M. Mihm,et al.  Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. , 1993, Annals of surgery.

[15]  S. Singletary,et al.  Melanoma With Metastasis to Regional Axillary or Inguinal Lymph Nodes: Prognostic Factors and Results of Surgical Treatment in 714 Patients , 1988, Southern medical journal.

[16]  D. Krag,et al.  Gamma-probe guided localization of lymph nodes. , 1993, Surgical oncology.

[17]  D. Sullivan,et al.  Lymphoscintigraphy in malignant melanoma: 99mTc antimony sulfur colloid. , 1981, AJR. American journal of roentgenology.

[18]  N. Cascinelli,et al.  Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities , 1982, Cancer.

[19]  M. Ross.  The Case for Elective Lymphadenectomy , 1992 .

[20]  L. S. Graham,et al.  The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: a preliminary study. , 1978, Surgery.

[21]  N. Cascinelli,et al.  Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. , 1977, The New England journal of medicine.

[22]  C. Balch,et al.  A Multifactorial Analysis of Melanoma: III. Prognostic Factors in Melanoma Patients with Lymph Node Metastases (Stage II) , 1981, Annals of surgery.

[23]  N. Cascinelli,et al.  Stage I Melanoma of the Limbs. Immediate versus Delayed Node Dissection , 1980, Tumori.

[24]  P. Schneider,et al.  A simplified technique to resect abnormal bony radiolocalizations using a gamma counter. , 1992, Surgical oncology.

[25]  D L Morton,et al.  Technical details of intraoperative lymphatic mapping for early stage melanoma. , 1992, Archives of surgery.

[26]  L. Bennett,et al.  Cutaneous lymphoscintigraphy in malignant melanoma. , 1983, Seminars in nuclear medicine.

[27]  C. Balch,et al.  Tumor thickness as a guide to surgical management of clinical stage I melanoma patients , 1979, Cancer.

[28]  C. Balch,et al.  Thin Stage I Primary Cutaneous Malignant Melanoma , 1988 .

[29]  D. Weaver,et al.  Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. , 1993, Surgical oncology.